podcast
details
.com
Share
Lung Cancer Considered
FDA Approval: Zongertinib for HER2 Mutant NSCLC
Listen
Description
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
podcast
details
Print
Share
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
Check it
Made by
Alex Barredo
. Send your feedback to
alex@barredo.es
.
